FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to using a compound of double NK-1/NK-3 receptor antagonists of formula A or its pharmaceutically acceptable salt for preparing a drug for treating vasomotor symptoms.
EFFECT: double neurokinin-1/neurokinin-3 receptor antagonists are proposed for treating sex hormone-dependent diseases.
7 cl, 2 tbl, 1 ex
Authors
Dates
2021-02-16—Published
2016-05-16—Filed